Crossmark

MTHFD2 is a potential oncogene for its strong association with poor prognosis and high level of immune infiltrates in urothelial carcinomas of bladder

Crossref DOI link: https://doi.org/10.1186/s12885-022-09606-0

Published Online: 2022-05-17

Published Print: 2022-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zhu, Lin

Liu, Xianhui

Zhang, Weiyu

Hu, Hao

Wang, Qi

Xu, Kexin
License Information

Text and Data Mining valid from 2022-05-17

Version of Record valid from 2022-05-17
More Information

Article History

Received: 9 September 2021

Accepted: 25 April 2022

First Online: 17 May 2022

Declarations

:

: The present study was approved by the Ethics Committee of Peking University People’s Hospital. The processing of clinical tissue samples is in accordance with the Helsinki Declaration. No consent was required as experimental data with no personal identifiers was used.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below